Moderna, Inc. vs ON Holding AG — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while ON Holding AG trades at $37.31 (market cap $12.55B). The key difference: Moderna, Inc. is the larger of the two by market cap, and Moderna, Inc. is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| MRNA | ONON | |
|---|---|---|
Market Cap | $23.60B | $12.55B |
Sector | Health | Technology |
52-Week High | $81.80 | $53.21 |
52-Week Low | $22.36 | $31.88 |
Enterprise Value | $19.70B | $11.87B |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →